We imagine. We create. We innovate.
We are a team of skilled R&D professionals with extensive experience in academia and industry. Our combined expertise spans over the entire R&D process, from idea generation to post-launch product support. We have contributed to the development of multiple consumer and therapeutic products that are available on the global market. Our name is derived from ‘imunotherapy via control of the tumor microenvironment’.
Dr. Thakoersing is a skin biologist with 13 years of experience in academia, fast-moving consumer goods, and the pharmaceutical industry, in both pre-clinical and clinical development. She has led various project teams that have contributed to pre-clinical and clinical lead validation, including phase III clinical trials for the paediatric population. Varsha has wide-ranging experience from a research management position at Unilever to clinical supply chain manager at Astellas. She holds a Ph.D. in skin biology and an M.Sc. in Biopharmaceutical Sciences both from Leiden University, Leiden, The Netherlands.
Paul Oranje is a cell biologist with 19 years of experience in R&D. He is specialized in cell and molecular biology assay development and pre-clinical drug discovery. He started his career at Amsterdam Molecular Therapeutics, the precursor of uniQure, as a junior project leader working on purification of viral gene therapy vectors. As a scientist at Unilever R&D, he has contributed to identification of (immuno)active ingredients for food and personal care products and is registered as inventor on a resulting patent. He also has experience in post-launch product support, including investigating patent infringement by competitors. Paul holds an M.Sc. in Drug Innovation from Utrecht University, Utrecht, The Netherlands.
Dr. Motta is an immunologist with 20 years of experience in R&D, with a special focus on translational sciences. He has led and contributed to numerous global R&D projects to fill Unilever’s R&D pipeline. During his career, Alex has held various research positions with increasing responsibilities at University Medical Center Groningen and Unilever. He holds a Ph.D. in immunology from Université Pierre et Marie Curie, Paris, France, and Dutch National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands. In 2018 he founded IMcoMET to develop the concept of ‘Local Microfluidic Therapy’ and translate it into a therapeutic innovation.
Sanne is a 4th year bachelor student “Biologie en Medisch Laboratoriumonderzoek” at the Rotterdam University of Applied Sciences. For her graduation internship she is currently optimising IMcoMET’s in vitro research tool “The Porcupine” and analysing the effect of tumoroid microenvironment flushing with a variety of methods, such as the Proteome Profiler array. Sanne also supports day to day lab operations and helps with the optimisation of different protocols. She is becoming proficient at 3D cell culture and her fresh ideas are of great help to the team.
We have the knowledge, expertise, and dedication to get the job done. We have a fully equipped ML-2 lab, specialized equipment, and industrial quality 3D printers. We create our own prototypes, complex cell assays, and analytical methods. We value a healthy work/life balance. We celebrate all our wins no matter how small, and find ways to incorporate our interests into our work.
IMcoMET has several internship positions available throughout the year. Are you interested in cell culture and/or biomedical engineering? Send us your resume, grades, and a motivation letter.
Requirements for an internship at IMcoMET:
Working at IMcoMET means working in an inspiring start-up environment. You will contribute to the development of a unique technology aimed at revolutionizing cancer therapy and diagnostics. And you will have the opportunity to develop yourself, implement your ideas, and be involved in substantial decision making from day 1. Do you have the entrepreneurial drive? Then contact us and introduce yourself!
